Enhancer redundancy predicts gene pathogenicity and informs complex disease gene discovery

BioRxiv : the Preprint Server for Biology
Xinchen Wang, David B Goldstein

Abstract

Non-coding transcriptional regulatory elements are critical for controlling the spatiotemporal expression of genes. Here, we demonstrate that the number of bases in enhancers linked to a gene reflects its disease pathogenicity. Moreover, genes with redundant enhancer domains are depleted of cis-acting genetic variants that disrupt gene expression, and are buffered against the effects of disruptive non-coding mutations. Our results demonstrate that dosage-sensitive genes have evolved robustness to the disruptive effects of genetic variation by expanding their regulatory domains. This resolves a puzzle in the genetic literature about why disease genes are depleted of cis-eQTLs, suggesting that eQTL information may implicate the wrong genes at genome-wide association study loci, and establishes a framework for identifying non-coding regulatory variation with phenotypic consequences.

Related Concepts

Gene Expression
Genes
Literature
Gene Mutant
BAT Loci
Transcriptional Regulation
Protein Expression
Genome-Wide Association Study

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Nature Reviews. Genetics
François Spitz, Eileen E M Furlong
Trends in Genetics : TIG
Douglas Vernimmen, Wendy A Bickmore
Molecular and Cellular Biology
K E Sullivan, B M Peterlin
© 2021 Meta ULC. All rights reserved